Vicagrel

Vicagrel is a potent, safe and orally active antiplatelet agent, which works by irreversibly inhibiting P2Y12 receptor. Vicagrel can be used for the research of blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease[1][2].

Product Specifications

CAS Number

[1314081-53-2]

UNSPSC

12352005

Target

P2Y Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein

Applications

COVID-19-immunoregulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/vicagrel.html

Purity

99.92

Solubility

DMSO : 250 mg/mL (ultrasonic)

Smiles

O=C(OC)[C@@H](N1CCC2=C(C=C(OC(C)=O)S2)C1)C3=CC=CC=C3Cl

Molecular Formula

C18H18ClNO4S

Molecular Weight

379.86

References & Citations

[1]French, et al. Method for preparing vicagrel. Patent. WO2014040498A1. |[2]Jiaqi Shan, et al. Overcoming clopidogrel resistance: discovery of vicagrel as a highly potent and orally bioavailable antiplatelet agent. J Med Chem